Pharmacist-Driven Deprescribing to Reduce Anticholinergic Burden in Veterans With Dementia
This quality improvement project suggests that with the use of population health management tools and in collaboration with the interdisciplinary team, pharmacists can identify and deprescribe inappropriate anticholinergic medications. Pharmacists can provide evidence-based recommendations to guide risk-benefit discussion and consider safer nonanticholinergic alternatives (both pharmacologic and nonpharmacologic), aiding in anticholinergic deprescribing.
Authors
- Bailey Deglow
Institutions
- VA St. Louis Health Care System (US)
Publication Details
- Journal
- Federal Practitioner
- Published
- 2024-12-01
- DOI
- https://doi.org/10.12788/fp.0539
- Citations
- 1
- Primary Topic
- Pharmaceutical Practices and Patient Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.34